NAD+ injection side effects: what is common, what is not, and when to call

Why the delivery route changes how it feels

With an IV drip, NAD+ enters the bloodstream directly, and how fast it runs makes a big difference to how people feel. Clinics that offer IV NAD+ commonly describe flushing, chest tightness, nausea and abdominal cramping when the drip runs fast, and slowing the rate is the usual fix. These reports come largely from clinical experience rather than controlled trials.

A subcutaneous injection goes into the fatty tissue under the skin and is absorbed gradually. That slower entry is the main reason IV-style reactions are less common with injections. In a 2019 pilot study published in Frontiers in Aging Neuroscience, eight healthy men received a slow 6-hour IV infusion of 750 mg NAD+, and the authors reported no adverse events. That is reassuring about slow delivery but far too small to define a safety profile.

Common effects with injections

• Redness, tenderness, mild swelling or a small bruise at the injection site
• A brief feeling of warmth or flushing shortly after the dose
• Mild nausea or stomach discomfort
• Tiredness or, less often, feeling wired on the day of the injection
• Headache or light-headedness
• A stinging sensation as the medicine goes in

Reducing the common ones

Your clinician and pharmacist will show you how to inject, and good technique prevents a lot of site problems. Rotating injection spots, letting the medicine reach room temperature if your instructions allow, and injecting slowly can all help. Eating a light meal beforehand and staying hydrated may ease nausea.

If a side effect keeps coming back or bothers you, tell your clinician rather than adjusting the dose on your own. The dose and schedule are set by your clinician, and changes should go through them.

Keep supplies clean, use a new needle each time, and dispose of sharps in a proper container. Most site infections are preventable with these simple habits.

Stop and seek care right away if you notice

• Hives, a spreading rash or itching all over
• Swelling of the lips, face, tongue or throat, or trouble breathing; call 911
• Chest pain or pressure that does not settle quickly
• A racing or irregular heartbeat, or fainting
• An injection site that becomes hot, increasingly red, swollen or painful, or produces pus, which may signal infection
• Fever after an injection

Allergic reactions

Serious allergic reactions appear to be rare, but they can occur with any injected product. With compounded medicines, the inactive ingredients, such as preservatives or buffers, can occasionally be the cause rather than NAD+ itself. Tell your clinician about any past reactions to injections or preservatives before starting.

What we know, and do not know, about safety

Research on raising NAD+ in people is still young. Oral precursors have the most data. In a 2018 randomized crossover trial in Nature Communications, 24 healthy adults aged 55 to 79 took nicotinamide riboside for six weeks; it raised NAD+ in blood cells by about 60 percent and adverse events were mild, but the authors cautioned that the study was too small to establish a broad safety profile.

For subcutaneous NAD+ injections specifically, there are no long-term controlled studies. We do not know the effects of years of use, and we cannot rule out uncommon problems. That uncertainty is part of the conversation before you start.

Who should be more cautious

• People who are pregnant or breastfeeding: not recommended, because there are no safety data
• People with active cancer or a history of cancer, since NAD+ supports cell energy and repair in all cells; discuss with your oncologist
• People with significant heart rhythm problems, or liver or kidney disease
• People taking many medicines, because interaction data are limited
• Anyone with a history of reactions to injections or compounded products

Keeping a simple side-effect log

For the first few weeks, jot down the date, the injection site, how you felt in the hours afterward and anything else that changed, such as sleep, caffeine or alcohol. This makes follow-up visits more productive and helps your clinician tell whether a symptom is related to NAD+ or to something else. Bring the log, or a photo of any site reaction, to your follow-up.

FDA status and what that means for you

NAD+ injections from HealifyMD are compounded by a licensed U.S. pharmacy. The FDA states that compounded drugs are not FDA-approved and that it does not verify their safety, effectiveness or quality before they are marketed. NAD is listed by the FDA in Category 1 of bulk substances under evaluation for 503A compounding. The price is from $199/month, confirmed at your eligibility review, and a licensed clinician follows up on how you are tolerating it.